TILT Biotherapeutics raises $10M to push ahead on cancer immunotherapies
TILT Biotherapeutics (TILT), a clinical-stage Finnish biotech company developing cancer immunotherapies, has completed the first…
15/06/2022 - 2 minutes
Cancer: Keep up to Date with the Latest in Oncology
As one of the leading causes of death worldwide, cancer receives great focus from the life sciences industry. Indeed, it’s the largest therapeutic focus area for biotech and pharma companies, which are working on a large number of therapeutic approaches, including small molecules, T cell therapies, and antibody therapies.
Global cancer drug sales are estimated to reach €221B by 2024. The top 10 blockbuster drugs are sold by big pharma companies, like Roche, Merck, AbbVie, and Bristol-Myers Squibb. Examples of blockbusters include Keytruda, Rituxan, and Herceptin.
Biotech companies are doing a fair bit of the work as well. Read on to keep up to date with the latest oncology research, discoveries, and market developments.
Show More
Editor's Picks for Cancer
- A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
- Immuno-Oncology: From Science Fiction to the Mainstream
- ADC Approval Buoys Spirits in Cancer Treatment Space
- Do Natural Killer Cells Hold the Key to Treating Blood Cancers?
- Meet 20 European Immuno-Oncology Companies that are Fighting Cancer
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportLatest Cancer Articles
Japan’s five hottest biotech companies in healthcare
While historically lacking in foreign investments, Japan’s biotech scene is thriving with global investors showing…
15/06/2022 - 6 minutes
Amaroq Therapeutics ‘hits early milestones’ in cancer treatment
New Zealand biotech company Amaroq Therapeutics said it is progressing towards clinical trials following a…
09/06/2022 - 2 minutes
Neuroendocrine cancer under the spotlight as Ariceum Therapeutics launches
Ariceum Therapeutics, a private biotech company developing a radiopharmaceutical product for the diagnosis and systemic…
08/06/2022 - 2 minutes
Cancer vaccine biotech CimCure raises €5M
Dutch biotech company CimCure, which is focusing on the development of vaccine-based cancer immunotherapy, has…
07/06/2022 - 3 minutes
ImmunOs Therapeutics raises $74M
ImmunOs Therapeutics AG, a biopharmaceutical company developing therapeutics for the treatment of cancer and autoimmune…
07/06/2022 - 3 minutes
ANGLE and U.S. urology group to undertake prostate cancer study
ANGLE plc has signed a master clinical study agreement with Solaris Health Holdings, LLC and…
31/05/2022 - 5 minutes
HotSpot looks to boost cancer therapy pipeline with Excelra partnership
U.S. biotech company HotSpot Therapeutics, Inc. is looking to increase its drug development and discovery…
27/05/2022 - 2 minutes
Companies partner on early lung cancer detection blood test
U.S. company CorePath Laboratories is partnering with U.K. diagnostics firm Cizzle Biotechnology on an early-stage…
27/05/2022 - 3 minutes
Duke Street Bio enters stage with next-generation cancer therapies
The UK startup Duke Street Bio has exited stealth mode with funding to develop PARP…
25/05/2022 - 3 minutes
Domain Therapeutics Bags €39M to Block GPCRs in Cancer Immunotherapy
Domain Therapeutics, a biopharmaceutical company in France and Canada developing cancer immunotherapies targeting G protein-coupled…
13/05/2022 - 4 minutes
Exosome Therapy: Borrowing from Nature’s Toolbox
In just a few years, exosomes have started gaining recognition as a solution to deliver…
09/05/2022 - 11 minutes
